- Home
- ODYS vs BTMD Comparison
ODYS vs BTMD Comparison
Compare ODYS & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ODYS
- BTMD
- Stock Information
- Founded
- ODYS N/A
- BTMD 2012
- Country
- ODYS Israel
- BTMD United States
- Employees
- ODYS N/A
- BTMD N/A
- Industry
- ODYS
- BTMD Medicinal Chemicals and Botanical Products
- Sector
- ODYS
- BTMD Health Care
- Exchange
- ODYS NYSE
- BTMD Nasdaq
- Market Cap
- ODYS 86.1M
- BTMD 102.3M
- IPO Year
- ODYS N/A
- BTMD N/A
- Fundamental
- Price
- ODYS $5.36
- BTMD $3.91
- Analyst Decision
- ODYS Strong Buy
- BTMD Strong Buy
- Analyst Count
- ODYS 1
- BTMD 1
- Target Price
- ODYS $10.00
- BTMD $8.00
- AVG Volume (30 Days)
- ODYS 32.2K
- BTMD 178.0K
- Earning Date
- ODYS 03-28-2025
- BTMD 05-07-2025
- Dividend Yield
- ODYS N/A
- BTMD N/A
- EPS Growth
- ODYS N/A
- BTMD 201.68
- EPS
- ODYS N/A
- BTMD 0.60
- Revenue
- ODYS $3,964,000.00
- BTMD $199,379,000.00
- Revenue This Year
- ODYS N/A
- BTMD $6.20
- Revenue Next Year
- ODYS N/A
- BTMD $9.24
- P/E Ratio
- ODYS N/A
- BTMD $6.46
- Revenue Growth
- ODYS 30.70
- BTMD 6.44
- 52 Week Low
- ODYS $5.01
- BTMD $3.04
- 52 Week High
- ODYS $10.80
- BTMD $8.44
- Technical
- Relative Strength Index (RSI)
- ODYS N/A
- BTMD 58.93
- Support Level
- ODYS N/A
- BTMD $3.15
- Resistance Level
- ODYS N/A
- BTMD $4.40
- Average True Range (ATR)
- ODYS 0.00
- BTMD 0.24
- MACD
- ODYS 0.00
- BTMD 0.09
- Stochastic Oscillator
- ODYS 0.00
- BTMD 60.80
About ODYS ODYSIGHT AI INC
Odysight ai Inc is engaged in the development, production, and marketing of Predictive Maintenance (PdM) and Condition Based Monitoring (CBM) technologies, providing visual sensing and AI-based video analytics solutions for critical systems in the aviation, maritime, industrial non-destructing-testing industries, transportation, and energy industries.
About BTMD Biote Corp.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries.